依布利特及胺碘酮用于心房颤动、心房扑动转复的对比研究  

作　　者：曾建敏 黄樱菲 叶广宁 鲁桓 

机构地区：[1]广东省阳江市人民医院,广东阳江529599

出　　处：《求医问药（下半月刊）》2012年第6期470-470,共1页Seek Medical and Ask The Medicine

摘　　要：目的:探讨依布利特及胺碘酮用于心房颤动、心房扑动转复的效果差异。方法:将63例房扑及60例房颤患者各随机分为二组,分别应用依布利特及胺碘酮治疗,转复为有效,未转复为无效。结果:依布利特对于房扑的转复率与胺碘酮对比有统计学意义(76.67%vs.27.27%,P<0.05),但对于房颤的转复依布利特与胺碘酮无差别(66.67%vs.48.15%,P>0.05);因此,依布利特转复房扑的成功率高于房颤。结论:依布利特转复房扑优于胺碘酮,其对房扑的转复成功率高于房颤。Objective：To investigate the according to Britt and amiodarone for atrial fibrillation,atrial flutter cardioversion of difference.Methods：63 cases of atrial flutter and60 patients with atrial fibrillation patients each were randomly divided into two groups,respectively,used by Britt and amiodarone therapy,changed to effective,was not changed to invalid.Results：according to Britt for the AFL ＇s conversion rate and amiodarone compared with statistical significance（76.67% vs.27.27%,P0.05）,but for atrial fibrillation cardioversion in Britt and amiodarone indifference（66.67% vs.48.15%,P0.05）;therefore,according to Britt cardioversion of atrial flutter in the success rate is higher than that of atrial fibrillation.Conclusion：according to Britt the cardioversion of atrial flutter is superior to amiodarone,the flutter cardioversion success rate is higher than that of atrial fibrillation.

关 键 词：房扑 房颤 依布利特 胺碘酮 

分 类 号：R541.7[医药卫生—心血管疾病]